Cargando…

Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction

(1) Background: Epiregulin (EREG) is a ligand of EGFR and ErB4 involved in the development and the progression of various cancers including head and neck squamous cell carcinoma (HNSCC). Its overexpression in HNSCC is correlated with short overall survival and progression-free survival but predictiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jehl, Aude, Conrad, Ombline, Burgy, Mickaël, Foppolo, Sophie, Vauchelles, Romain, Ronzani, Carole, Etienne-Selloum, Nelly, Chenard, Marie-Pierre, Danic, Aurélien, Dourlhes, Thomas, Thibault, Claire, Schultz, Philippe, Dontenwill, Monique, Martin, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000618/ https://www.ncbi.nlm.nih.gov/pubmed/36899869 http://dx.doi.org/10.3390/cells12050733

Ejemplares similares

Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids
por: Conrad, Ombline, et al.
Publicado: (2023)

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
por: Burgy, Mickaël, et al.
Publicado: (2021)

Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity
por: Cruz Da Silva, Elisabete, et al.
Publicado: (2022)

Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
por: Sani, Saidu, et al.
Publicado: (2022)

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction
por: Job, Sylvie, et al.
Publicado: (2019)

DIPG-31. HIF-1A AND HIF-2A COMBINATORIAL TARGETING OR HOW TO REVERSE THEIR BALANCED ONCOGENIC IMPACT
por: Fuchs, Quentin, et al.
Publicado: (2023)

Polymorphism in the EREG gene confers susceptibility to tuberculosis
por: Cao, Wen, et al.
Publicado: (2019)

The Role of EREG/EGFR Pathway in Tumor Progression
por: Cheng, Wan-Li, et al.
Publicado: (2021)

BMP7 and EREG Contribute to the Inductive Potential of Dental Mesenchyme
por: Gao, Bo, et al.
Publicado: (2015)

EREG is a risk factor for the prognosis of patients with cervical cancer
por: Li, Tianye, et al.
Publicado: (2023)

Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
por: Yi, Renxin, et al.
Publicado: (2020)

Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression
por: Miao, Yu, et al.
Publicado: (2022)

Extracellular CIRP Promotes GPX4-Mediated Ferroptosis in Sepsis
por: Shimizu, Junji, et al.
Publicado: (2022)

Copper-dependent autophagic degradation of GPX4 drives ferroptosis
por: Xue, Qian, et al.
Publicado: (2023)

GPX7 Is Targeted by miR-29b and GPX7 Knockdown Enhances Ferroptosis Induced by Erastin in Glioma
por: Zhou, Yan, et al.
Publicado: (2022)

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2(nd) Line Cetuximab-Based Therapy of Colorectal Cancer Patients
por: Saridaki, Zacharenia, et al.
Publicado: (2011)

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
por: Cruz Da Silva, Elisabete, et al.
Publicado: (2021)

CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma
por: Wang, Zhixian, et al.
Publicado: (2021)

GPX4-independent ferroptosis—a new strategy in disease’s therapy
por: Ma, Tianyu, et al.
Publicado: (2022)

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
por: Burgy, Mickaël, et al.
Publicado: (2019)

FINO(2) Initiates Ferroptosis Through GPX4 Inactivation and Iron Oxidation
por: Gaschler, Michael M., et al.
Publicado: (2018)

Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?
por: Conrad, Marcus, et al.
Publicado: (2015)

Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis
por: Thayyullathil, Faisal, et al.
Publicado: (2021)

GPX4 Alleviates Diabetes Mellitus-Induced Erectile Dysfunction by Inhibiting Ferroptosis
por: Xu, Wenchao, et al.
Publicado: (2022)

KLF11 regulates lung adenocarcinoma ferroptosis and chemosensitivity by suppressing GPX4
por: Zhao, Guangyin, et al.
Publicado: (2023)

Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells
por: Renner, Guillaume, et al.
Publicado: (2016)

The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis
por: Bersuker, Kirill, et al.
Publicado: (2019)

Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI
por: Chen, Chuan’ai, et al.
Publicado: (2021)

A cell state specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma
por: Banu, Matei A., et al.
Publicado: (2023)

Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells
por: Wang, Zeyu, et al.
Publicado: (2023)

Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
por: Lee, Michael S, et al.
Publicado: (2016)

RHOA GTPase Controls YAP-Mediated EREG Signaling in Small Intestinal Stem Cell Maintenance
por: Liu, Ming, et al.
Publicado: (2017)

DIPG-30. HIF2 OVEREXPRESSION DICTATES AGGRESSIVENESS ADDITIONALLY TO TP53 MUTATIONS IN H3.3K27M PEDIATRIC HIGH-GRADE GLIOMAS THROUGH RAS-MAPK AND WNT/BCATENIN PATHWAYS
por: Fuchs, Quentin, et al.
Publicado: (2023)

RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
por: Sui, Xinbing, et al.
Publicado: (2018)

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
por: Song, Xiang, et al.
Publicado: (2020)

Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis
por: Zhai, Feng-guo, et al.
Publicado: (2022)

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases
por: Cui, Can, et al.
Publicado: (2022)

Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer
por: Wang, Yue, et al.
Publicado: (2022)

Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling
por: Zhang, Weifan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dc53n98g4ue7v84rm8agvfh5o4